Form 4: Matson Inc. CEO Matthew Cox Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Matson Inc.'s Chairman and CEO, Matthew J. Cox, executed sales of common stock on June 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 28, 2024, Matthew J. Cox, Chairman and CEO of Matson, Inc., sold shares of common stock.
- The sales were executed under a Rule 10b5-1 trading plan adopted on February 23, 2024.
- A total of 3,400 shares were sold at a weighted average price of $130.0842, with individual trades ranging from $129.46 to $130.43.
- An additional 4,443 shares were sold at a weighted average price of $130.8953, with individual trades ranging from $130.53 to $131.32.
- Following these transactions, Matthew Cox directly owns 230,397 shares of Matson, Inc. common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan, which is a routine event.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider information being used for personal gain.
Key Dates
| Date | Description |
|---|---|
| February 23, 2024 | Date the Rule 10b5-1 trading plan was adopted by Matthew J. Cox. |
| June 28, 2024 | Date of the reported stock sales. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.